Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Return on Sales (2016 - 2026)

Healthequity has reported Return on Sales over the past 14 years, most recently at 0.15% for Q1 2026.

  • Quarterly results put Return on Sales at 0.15% for Q1 2026, up 6.0% from a year ago — trailing twelve months through Jan 2026 was 0.16% (up 8.0% YoY), and the annual figure for FY2026 was 0.16%, up 8.0%.
  • Return on Sales for Q1 2026 was 0.15% at Healthequity, down from 0.16% in the prior quarter.
  • Over the last five years, Return on Sales for HQY hit a ceiling of 0.18% in Q3 2025 and a floor of 0.16% in Q1 2022.
  • Median Return on Sales over the past 5 years was 0.06% (2023), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Sales: dropped -19bps in 2022 and later rose 16bps in 2023.
  • Healthequity's Return on Sales stood at 0.01% in 2022, then skyrocketed by 875bps to 0.06% in 2023, then plummeted by -68bps to 0.02% in 2024, then surged by 746bps to 0.16% in 2025, then dropped by -7bps to 0.15% in 2026.
  • The last three reported values for Return on Sales were 0.15% (Q1 2026), 0.16% (Q4 2025), and 0.18% (Q3 2025) per Business Quant data.